This group conducts and supports prevention and early detection research on colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.
Barrett's Esophagus Translational Research Network (BETRNet)
Multi-disciplinary, multi-institutional collaboration to enhance understanding of Barrett's esophagus and to prevent esophageal adenocarcinoma.
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
Systematic early clinical development of promising preventive agents through five major medical research centers.